TNYA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tenaya Therapeutics Inc (TNYA) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, insider selling, and no positive catalysts or trading signals to support a buy decision.
The MACD is slightly positive at 0.00712, indicating weak bullish momentum. RSI at 57.243 is neutral, and moving averages are converging, showing no clear trend. Key resistance levels are at 0.765 and 0.798, while support levels are at 0.658 and 0.625. The stock is trading near its pivot point of 0.712, with no strong directional bias.
NULL. There are no recent news or events to act as positive catalysts for the stock.
Insider selling has increased by 55373.56% over the last month, which is a strong negative signal. Additionally, the stock has a 40% chance of declining by -2.2% in the next day, -3.13% in the next week, and -12.16% in the next month.
In Q4 2025, the company reported zero revenue growth (0% YoY), a net income loss of -$20,175,000 (down -15.36% YoY), and an EPS drop of -57.14% YoY to -0.12. Gross margin remains at 0%. These figures indicate poor financial health and no signs of growth.
No recent analyst ratings or price target changes are available for TNYA.
